Table 2. Comparison of procedural performance characteristics and adverse events in patients who received anesthesia-assisted deep sedation (AADS) and those who received Penthrox analgesia for colonoscopy.
AADS
(n = 55) |
Penthrox (n = 85) | P value | |
In-room preparation time, mean ± SD, min | 16.5 ± 1.8 | 4.8 ± 0.2 | < 0.01 |
Cecal arrival time, mean ± SD, min | 11.6 ± 1.0 | 8.8 ± 0.5 | < 0.01 |
Total colonoscopy time, mean ± SD, min | 25.9 ± 1.7 | 18.4 ± 0.9 | < 0.01 |
Total in-room time, mean ± SD, min | 51.6 ± 1.3 | 23.9 ± 0.9 | < 0.001 |
Patients with polypectomy, n (%) | 23 (44) | 46 (54) | 0.18 |
Patients with incomplete colonoscopy, n (%) due to severe sigmoid diverticulosis due to significant looping due to poor preparation |
3 (5) 1 1 1 |
1 (1) 0 1 0 |
0.39 |
Patients requiring intravenous fluid therapy during and after colonoscopy, n (%) | 55 (100) | 01 | < 0.001 |
Patients requiring oxygen supplementation to maintain SaO2 > 90 %, n (%) | 55 (100) | 01 | < 0.001 |
SD, standard deviation.
P < 0.01 vs. AADS.